Next Article in Journal
Achieving the Optimal AgO Concentrations to Modulate the Anti-Trypanosoma cruzi Activity of Ag-ZnO/AgO Nanocomposites: In Vivo Investigations
Next Article in Special Issue
Development and Application of Physiologically-Based Pharmacokinetic Model to Predict Systemic and Organ Exposure of Colorectal Cancer Drugs
Previous Article in Journal
Computational Analysis of S1PR1 SNPs Reveals Drug Binding Modes Relevant to Multiple Sclerosis Treatment
Previous Article in Special Issue
PBPK Modeling of Lamotrigine and Efavirenz during Pregnancy: Implications for Personalized Dosing and Drug-Drug Interaction Management
 
 
Review

Article Versions Notes

Pharmaceutics 2024, 16(11), 1414; https://doi.org/10.3390/pharmaceutics16111414
Action Date Notes Link
article xml file uploaded 3 November 2024 11:53 CET Original file -
article xml uploaded. 3 November 2024 11:53 CET Update https://www.mdpi.com/1999-4923/16/11/1414/xml
article pdf uploaded. 3 November 2024 11:53 CET Version of Record https://www.mdpi.com/1999-4923/16/11/1414/pdf
article supplementary file uploaded. 3 November 2024 11:53 CET - https://www.mdpi.com/1999-4923/16/11/1414#supplementary
article html file updated 3 November 2024 11:55 CET Original file https://www.mdpi.com/1999-4923/16/11/1414/html
Back to TopTop